Next Article in Journal
The Main Anticancer Bullets of the Chinese Medicinal Herb, Thunder God Vine
Next Article in Special Issue
Rauniticine-allo-Oxindole B and Rauniticinic-allo Acid B, New Heteroyohimbine-Type Oxindole Alkaloids from the Stems of Malaysian Uncaria longiflora var. pteropoda
Previous Article in Journal
Recent Advances in the Synthesis of N-Containing Heteroaromatics via Heterogeneously Transition Metal Catalysed Cross-Coupling Reactions
Previous Article in Special Issue
Identification of Diterpenoid Alkaloids from the Roots of Aconitum kusnezoffii Reihcb.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Acute Oral Toxicity of Methanolic Seed Extract of Cassia fistula in Mice

Subramanion L. Jothy
Zuraini Zakaria
Yeng Chen
Yee Ling Lau
Lachimanan Yoga Latha
2 and
Sreenivasan Sasidharan
Biological Program, School of Distance Education, Universiti Sains Malaysia, Minden 11800, Penang, Malaysia
Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800, Pulau Pinang, Malaysia
Department of Parasitology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
Author to whom correspondence should be addressed.
Molecules 2011, 16(6), 5268-5282;
Submission received: 23 May 2011 / Accepted: 22 June 2011 / Published: 23 June 2011
(This article belongs to the Special Issue Alkaloids: Novel Therapeutic Perspectives)


Background and objective: Cassia fistula is widely used in traditional medicine to treat various types of ailments. The evaluation of toxic properties of C. fistula is crucial when considering public health protection because exposure to plant extracts can result in undesirable effects on consumers. Hence, in this study the acute oral toxicity of C. fistula seeds extract was investigated in mice. Results: Oral administration of crude extract at the highest dose of 5000 mg/kg resulted in no mortalities or evidence of adverse effects, implying that C. fistula in nontoxic. Throughout 14 days of the treatment no changes in behavioural pattern, clinical sign and body weight of mice in both control and treatment groups. Also there were no any significant elevations observed in the biochemical analysis of the blood serum. Further, histopathological examination revealed normal architecture and no significant adverse effects observed on the kidney, heart, liver, lung and spleen. Conclusions: Overall, the results suggest that, the oral administration of C. fistula methanolic seeds extract did not produce any significant toxic effect in mice. Hence, the extract can be utilized for pharmaceutical formulations.

1. Introduction

Traditional and alternative medicine is extensively practiced in the prevention, diagnosis, and treatment of various illnesses. It has attracted increasing public attention over the past 20 years as this type of medicine is easily accessible in some regions [1]. Plant-derived foods, particularly vegetables and fruits, are generally considered to be highly beneficial components of the human diet. They contribute great importance in daily life by providing wide range of nutrients, vitamins and other compounds which widen the therapeutic arsenal. In general, natural products play a dominant role in the development of novel drug leads for the treatment and prevention of diseases [2].
Cassiafistula L., (Caesalpinioideae), a semi-wild Indian Labernum also known as the golden shower is distributed in various regions including Asia, South Africa, China, West Indies and Brazil. C. fistula exhibits significant antifungal activity and also used in treatment of some diseases as a broad-spectrum antifungal agent [3]. According to the Indian literature, this plant has been described for its pharmacopeia uses. The whole plant is used to treat diarrhea and particularly the seeds, flower and fruits are used to treat skin diseases, fever, abdominal pain and leprosy [4]. The root possess astringent, tonic, febrifugal, and purgative properties and therefore, is useful against cardiac disorders, biliousness, rheumatic condition, haemorrhages, wounds, ulcers and boils, tubercular glands and various skin diseases [5,6]. Meanwhile, the flowers are eaten raw and it possess astringent, purgative, febrifugal and wound healing properties and a decoction of the flowers is given for stomach troubles. The pulp is a safe purgative due to the wax aloin, so it’s recommended for children and pregnant women [7]. It is given in disorders of liver, and in biliousness, and used as a tonic also applied in gout and rheumatism [8,9]. Apart from that, the pulp is used as an antipyretic and it is a remedy for malaria and blackwater fever [10]. It is also utilized in cases of blood-poisoning, anthrax and dysentery, and given in leprosy and diabetes and for the removal of abdominal obstructions. Meanwhile, the seeds are slightly sweet and possess laxative, carminative, cooling and anti-pyretic properties and they are given in cases of constipation [11]. Moreover, botanicals are enjoying widespread use of plants for treatment of several ailments, but still little known about their toxicity and safety issue which are always a concern. Investigations on functional plants provide evidence for the presence of substances that are offer potential human health benefits. However, it should be a vital requirement to determine the toxic effects of some of the substances contained in the plants [12].
Toxicity is an expression of being poisonous, indicating the state of adverse effects led by the interaction between toxicants and cells. This interaction may vary depending on the chemical properties of the toxicants and the cell membrane, as it may occur on the cell surface, within the cell body, or in the tissues beneath as well as at the extracellular matrix. The toxic effects may take place prior to the binding of the toxicants to the vital organs such as liver and kidneys. Hence, evaluation of toxic properties of a substance is crucial when considering for public health protection because exposure to chemicals can be hazardous and results to adverse effects on human being. In practice, the evaluation typically includes acute, sub-chronic, chronic, carcinogenic and reproductive effects [13].
The present study aims to determine the toxicity of methanolic seeds extract of C. fistula using an acute oral toxicity test in animal models [14]. The acute oral toxicity testing was carried out on both sexes of animals under the Organization for Economic Cooperation and Development (OECD) guidelines [15].

2. Results and Discussion

2.1. General Sign and Behavioural Analysis

The toxic effect of methanolic seeds extract of C. fistula on the appearance and the general behavioural pattern of mice are shown in Table 1 and Table 2 respectively. No toxic symptoms or mortality were observed in any animals, which lived up to 14 days after the administration of methanol seeds extract at single dose level of 5000 mg/kg body weight. The behavioural patterns of animals were observed first 6 h and followed by 14 h after the administration and the animals in both vehicle-treated and extract-treated groups were normal and did not display significant changes in behavior, skin effects, breathing, impairment in food intake and water consumption, postural abnormalities and hair loss. In the treated group in first 6 hrs rapid heartbeat was observed after the administration, but it then become normal and this may due to the stress of receiving the oral administration of the extract.
Table 1. Potential toxic effects of the crude extracts of C. fistula seeds in mice.
Table 1. Potential toxic effects of the crude extracts of C. fistula seeds in mice.
Control aCrude extract bControl aCrude extract b
0/3 c0/30/30/3
a Control groups (treatment without crude extract); b test groups (treatment with 5000 mg/kg crude extract); c Number of dead mice/ number of mice used.
Table 2. General appearance and behavioral observations for control and treated groups.
Table 2. General appearance and behavioral observations for control and treated groups.
Observation Control groupTest group
6 h14 h6 h14 h
Skin and furNormalNormalNormalNormal
Mucous membraneNormalNormalNormalNormal
Behavioural patternsNormalNormalRapid heart beatNormal
a Not Observed.

2.2. Organ and Body Weight Statistical Analysis

The gross observations of systemic organs from control and extract treated mice are shown in Figure 1.
Figure 1. Gross observation of systemic organs: liver (A1 and A2), kidney (B1 and B2), lung (C1 and C2), heart (D1 and D2) and spleen (E1 and E2) from control and extract treated mice.
Figure 1. Gross observation of systemic organs: liver (A1 and A2), kidney (B1 and B2), lung (C1 and C2), heart (D1 and D2) and spleen (E1 and E2) from control and extract treated mice.
Molecules 16 05268 g001
The body weight as well as weights of vital organs of the animals were calculated and are recorded in Table 3. There were no significant changes in body weight. However, the weight of the principal organs showed a significant increment. All animals exhibited a normal increment in body weight without drastic difference between both control and treated groups. Table 3 shows the effect of extract on principal organ weights relative to body weight. There were no significant differences in the changes of each weight. The results revealed that, the essential organs such as kidney, liver, heart, lung and spleen were not adversely affected throughout the treatment. The absolute and relative organ weight of mice between extract treated and control groups shown statistically significant differences (P < 0.05). Extract treated mice showed increased organ weight.
Table 3. Effect of C. fistula seeds crude extract on organ-to-body weight index (%) in mice.
Table 3. Effect of C. fistula seeds crude extract on organ-to-body weight index (%) in mice.
OrgansOrgan body weight index
Kidney1.46 ± 0.20 *0.94 ± 0.27
Heart1.03 ± 0.27 *0.40 ± 0.02
Liver9.27 ± 0.70 *4.93 ± 0.50
Lung1.62 ± 0.53 *0.79 ± 0.03
Spleen1.77 ± 0.49 *0.79 ± 0.38
Body Weight (g)22.7 ± 0.7925.1 ± 1.00
Organ body index = (organ weight × 100)/body weight; crude extract of C. fistula seeds was administered to mice at a dose of 5000 mg/kg; values are mean ± SD (n = 3) at 5% level of significance (* = P < 0.05).

2.3. Histopathology Analysis

Macroscopic examination of the organs of the animals treated with extract showed no changes in color compared to control. Autopsy at the end of the experiment period revealed no apparent changes in the liver, kidney, lungs, heart and spleen organs from both control and treated mice in the histopathology analysis. The microscopic structures of the organs depicted through Figure 2 shows unnoticeable differences between the control and test groups. The microscopic examination revealed that, all the organs from the extract treated mice did not show any alteration in cell structure or any unfavorable effects when viewed under the light microscope using multiple magnification power. The structure or coordination of cells in extract treated organs more or less similar compared with the control organs.
Figure 2. Histological examination of heart (a), kidney (b), liver (c), lung (d) and spleen (d).
Figure 2. Histological examination of heart (a), kidney (b), liver (c), lung (d) and spleen (d).
Molecules 16 05268 g002

2.4. Biochemical Analysis

Table 4 shows the changes of biochemical parameters in the serum of female mice induced by C. fistula seed extract. In the female mice, there are no significant changes for the serum levels of total bilirubin levels (TBIL), alkaline phosphatase (ALP), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (P > 0.05) after oral administration of C. fistula seed extract.
Table 4. Changes of biochemical parameters in the serum of mice induced by C. fistula seed extract.
Table 4. Changes of biochemical parameters in the serum of mice induced by C. fistula seed extract.
GroupsTBIL (mmol/L)ALT (U/L)AST (U/L)ALP (U/L)
Control0.8 ± 0.215.5 ± 5.479.4 ± 24.278.3 ± 18.9
Treated0.9 ± 0.516.3 ± 4.378.7 ± 22.677.9 ± 19.7

2.5. Discussion

Phytotheraputic products from medicinal plants have become universally popular in primary healthcare, particularly in developing countries, and some have been mistakenly regarded as safe just because they are a natural source. Nevertheless, these bioactive products from medicinal plants are presumed to be safe without any compromising health effect, and thus widely used as self medication [16]. However, there is a lack of proven scientific studies on the toxicity and adverse effect of these remedies. Therefore, further acute oral toxicity study is vitally needed not only to identify the range of doses that could be used subsequently, but also to reveal the possible clinical signs elicited by the substances under investigation. It is also a useful parameter to investigating the therapeutic index of drugs and xenobiotics [17].
In general in vivo toxicity study is the toxicological analysis of many medicinal plants and its potency to evaluate qualitatively and quantitatively by histopathology and oral acute toxicity studies. Oral acute toxicity testing in mice could be used to evaluate natural remedies for different pharmacological activities, taking into account the basic premise that pharmacology is simply toxicology at a lower dose [18]. A toxic substance might elicit interesting pharmacological effects at a lower non-toxic dose. Toxicity results from animals will be crucial in definitively judging the safety of medicinal plants if they are found to have sufficient potential for development into pharmacological products [19]. As use of medicinal plants increases, experimental screening of the toxicity of these plants is crucial to assure the safety and effectiveness of those natural sources. However, acute toxicity studies do not detect effects on vital functions like the cardiovascular, central nervous, and respiratory systems which are not usually assessed during the study and these should be evaluated prior to human exposure [20]. Moreover, acute toxicity is mainly to obtain an appropriate dose for long-term toxicity tests and to find out the affected organs at the end of the treatment. The previous study on preliminary toxicity analysis of C. fistula seeds extract by using brine shrimp lethality test have documented the seeds extract are not toxic and shows that, the extract can further explored for the development of natural product based pharmaceutical products [21]. Hence, the present study was particularly designed to further investigate toxicity of methanolic seeds extract of C. fistula by using acute oral toxicity analysis.
In this oral acute toxicity study, the Swiss albino mice were employed to observe the toxicity effects of the methanol crude extract of C. fistula seeds. The route of administration depends on the dosage form in which the compound is available. Based on historical research, the oral route administration is the most convenient and commonly used one when studying acute toxicity. The absorption might be slow, but this method costs less and is painless to the animals. Since the crude extract is administered orally, the animals should be fasted before taking the dose because food and other chemicals in the digestive tracts may affect the reaction(s) of the compound. Although there is a problem regarding extrapolating animals’ data to humans, a study has shown that mice give better prediction for human acute lethal dose compared to rats [22]. All the procedures were performed based on the appropriate OECD guideline [15].
In this study, the mice in the control and treated groups were administrated with vehicles and crude extract, respectively. The mice were monitored daily until day fourteen for any toxic signs and mortality. The clinical symptom is one of the major important observations to indicate the toxicity effects on organs in the treated groups [23]. During the 14 days of period acute toxicity evaluation, mice which are orally administrated with methanolic seeds extract at single dose 5000 mg/kg showed no overt signs of distress, and there were no observable symptoms of either toxicity nor deaths. All of the mice gained weight and displayed no significant changes in behavior. Apart from that, the physical appearance features such as skin, fur and eyes were found to be normal and whilst the body weight of the mice showed as increase (Table 2 and Table 3), this indicates that the administration of the crude extract has negligible level of toxicity on the growth of the animals. Furthermore, determination of food intake and water consumption is important in the study of safety of a product with therapeutic purpose, as proper intake of nutrients is essential to the physiological status of the animal and to the accomplishment of the proper response to the drugs tested [24,25]. In this study, the food intake and water consumption also was not affected by the administration of methanolic seeds extract of C. fistula and it did not induce appetite suppression and had no deleterious effects. Thus, this indicates there was no disturbance in carbohydrate, protein or fat metabolism [26].
Generally, the alterations of body weight gain and internal organ weights of mice would reflect the toxicity after exposure to the toxic substances [27]. The body weight changes are indicators of adverse effects of drugs and chemicals and it will be significant if the body weight loss occurred is more than 10% from the initial weight [28,29]. Organ weight also is an important index of physiological and pathological status in animals. The relative organ weight is fundamental to diagnose whether the organ was exposed to the injury or not. The heart, liver, kidney, spleen and lungs are the primary organs affected by metabolic reaction caused by toxicant [30]. The gross observation of systemic organs of both control and treated groups are shown in Figure 1. There is no changes were observed in gross observation of systemic organs of both control and treated groups. In this study, the relative and absolute of organs weight in both control and treated groups was increased significantly which shows that the extract nurtures the organs (Table 3). Differently, then body weight gain was same in both control and treated groups the difference were not statistically significant. The, administration of methanolic seeds extract did not show any adverse affect on organs weight of all important organs. Hence, it can be suggested that, C. fistula seeds extract is virtually nontoxic.
This study reckoned that C. fistula seeds extracts do not cause acute toxicity effects and an LD50 value greater than 5000 mg/kg. In principle, the limit test method is not intended for determining a precise LD50 value, but it serves as a suggestion for classifying the crude extract based on the expectation at which dose level the animals are expected to survive [31]. According to the chemical labeling and classification of acute systemic toxicity recommended by OECD, the crude extract of C. fistula seeds was assigned class 5 status (LD50 > 5000 mg/kg) which was the lowest toxicity class. According to the study by Kennedy et al. [32] substances with LD50 values higher than 5000 mg/kg by oral route are regarded as being safe or practically non-toxic. Meanwhile, a study done by Ilavarasan et al. [33] using Cassia fistula methanolic bark extract revealed that extract did not cause any mortality up to 2000 mg/kg and was thus considered as safe. Similar results were found for a single dose at 2000 mg/kg oral administration of C. spectabilis leaf extracts that was shown to be non-toxic to the tested mice [34].
Apart from that, histological analysis was done to further confirm the alteration in cell structure of the organs. The histological examination is the golden standard for evaluating treatment related pathological changes in tissues and organs [35]. In the present study, histopathological evaluation of acute oral ingestion of C. fistula seeds indicated that the extract did not adversely affect the morphology of mice organs. This agrees with the results of biochemical analysis, and oral administration of 5000 mg/kg for 14 days was well tolerated by the treated mice. In general, the histopathology analysis collaborated with the results of body weight and organ weight. The seeds extract of C. fistula did not cause toxicity towards the organs as there was no structural damage to the tested organs of liver, kidney, lungs, and spleen of the mice. The liver is the main target organ of acute toxicity where exposed to the foreign substances being absorbed in intestines and metabolized to other compounds which may or may not be hepatotoxic to the mice [36]. In this study, the liver histology revealed evidence determines normal hepatocytes and did not cause any alteration to the structure of the liver cells between the controls and treated (Figure 2c). In contrast, the histological examination study conducted by Harizal et al. [37] using Mitragyna speciosa extract revealed less severe morphological changes in liver of mice treated with extract at dose level 100 and 500 mg/kg. Meanwhile, the other study by Salawu et al. [38] using Crossopteryx febrifuga saw inflammatory changes histologically in the liver by infiltration of lymphocytes at portal and central of rat treated with at dose level 500 and 1000 mg/kg and this shows that, the extract exerted deleterious effects on the liver. The liver is capable of regenerating damaged tissue, hence the liver function may not be impaired early following an insult from a toxicant [38]. Apart from that, the acute toxicity study conducted on C. fistula pod extract and histological examination of the organs of rat treated with extract at a dose of 1000 mg/kg revealed that there was no potential toxicity or damage to the cell structure of liver, kidney and testes. Also there was no necrosis, inflammatory reaction, fibrosis or local fatty degeneration observed in liver and the arrangement of cell structure almost similar to the organs of rats in control groups [39]. The histological features liver from this study are displayed in Figure 2c and marked with central vein and portal triad. The morphology of liver cell in both control and treated groups are normal and no structural damages were observed.
The kidney micrograph displayed in Figure 1b shows that no adverse effects were observed in both groups and the glomeruli and capsules appeared normal and the Bowman’s space are also marked clearly. In contrast, the study conducted by Alade et al. [40] revealed the histology of kidney observed with focal proximal tubular epithelial necrosis, meanwhile there was variation in the lung between the control and treated with rat B. monandra leaf extract at dose 4 g/kg. Apart from that, the study conducted by Akanmu et al. [39] on C. fistula pods extract revealed that there were slight changes in the histology of kidney from the rat treated with extract at dose 1000 mg/kg where some of the glomeruli and the proximal tubules was observed to widen without any injury compared to the control. Furthermore, in this study the microscopic inspection of the lung and heart (Figures 2 a,d) of the mice treated with extract did not indicate any changes in the organs compared to control mice. Meanwhile, histology of the spleen (Figure 2e) of mice in both control and treated groups are well labeled with white pulp and red pulp.
The hematopoietic system is very sensitive to toxic compounds and serves as an important index of the physiological and pathological status in both animals and humans [41]. After 14 days of treatment with C. fistula seeds extract there was no changes in the hematological parameters between the control and treatment groups. This indicates that there were no significant changes of serum levels of TBIL, ALP, ALT and AST hence, verifying the non toxic nature of C. fistula seed extract. This finding also supports the usage of these seeds in traditional medicine by the traditional healers. However, the normal range of this parameter can be altered by the intake of toxic plants [42] which was not observed in this study.

3. Experimental

3.1. Plant Materials

Fresh pods of Cassia fistula were collected from various areas in Universiti Sains Malaysia, Penang in November 2010 and authenticated by the botanist of the School of Biological Sciences at Universiti Sains Malaysia where the herbarium sample was deposited. The sun-dried pods were cut open and the seeds removed from the pods. The seeds were then washed thoroughly and rinsed with tap water and dried in oven at 60 °C for three to four days. Then the dried seeds were homogenized to a fine powder and stored in airtight bottles.

3.2. Preparation of Crude Extracts

The seed sample was sequentially extracted with methanol by adding approximately 100 g of the dried sample (in fine powder form) to 400 mL methanol. The extraction was carried out at room temperature by soaking for 7 days with intermittent stirring during the first day. The extracts were filtered through clean muslin cloth and the extraction process was repeated again for a second time by adding another 400 mL of methanol to the sample residue. The filtrate from each extraction was combined and concentrated under vacuum on a rotary evaporator (Buchi, Switzerland) at 40 °C to 50 °C in order evaporate the excess methanol solvent and until a dark green methanol extract was produced. The concentrated extract was poured into glass Petri plates and brought to dryness at 60 °C in the oven until a paste-like mass was obtained. Then paste form extract was sealed in Petri plates and stored at room temperature (RT). The crude extract was prepared by diluting the paste in methanol and storing in air-tight bottles at 4 °C for further studies.

3.3. Acute Oral Toxicity Study

3.3.1. Target Animal

The experiment was conducted on 12 healthy Swiss albino mice (males and females) weighing 25 g to 35 g and aged 8 to 10 weeks obtained from the Animal House, Universiti Sains Malaysia Penang. The mice were distributed into two groups. The experimental procedures relating to the animals were authorized Universiti Sains Malaysia Ethical committee (USM/ Animal Ethics Approval/ 2010/ (59) (262)) before starting the study and were conducted under the internationally accepted principles for laboratory animal use and care.

3.3.2. Acute Toxicity Assay

The mice were housed in cages and randomly selected ones were marked on the tail for individual identification. All mice were maintained on a 12-h light/dark cycle and located at room temperature approximately 23 °C with constant humidity. They were allowed to acclimatize to laboratory conditions for a week before starting the experiment. Drinking water and food were provided ad libitum throughout the experiment, except for the short fasting period where the drinking water was still in free access but no food supply was provided 12 h prior to treatment. The acute oral toxicity methanolic seed extract of C. fistula was evaluated in mice according to the procedures outlined by the Organization for Economic Co-operation and Development (OECD) [15]. A single high dose of 5,000 mg/kg of crude extract was administered to both three male mice and three female mice in the treatment groups by the oral route. The crude extract was suspended in a vehicle (distilled water). Following the fasting period, body weight of the mice were determined and the dose was calculated in reference to the body weight as the volume of the extracts solution given to the mice is 10 mL/kg. Another three male mice and three female mice were allotted distilled water and were regarded as the control groups. Food was provided to the mice approximately an hour after treatment. The mice were observed in detail for any indications of toxicity effect within the first six hours after the treatment period, and daily further for a period of 14 days. Surviving animals were weighed and visual observations for mortality, behavioral pattern, changes in physical appearance, injury, pain and signs of illness were conducted daily during the period.

3.4. Histopathological Analysis

3.4.1. Organs and Body Weight Statistical Analysis

Finishing the 14 days period, all the mice were sacrificed. Vital organs such as heart, kidneys, liver, lung and spleen were isolated and examined for any lesions. All of the individual organs were weighed and their features were compared between both treated and control groups.

3.4.2. Histopathology of Heart, Kidneys, Liver, Lung and Spleen

All the vital organs isolated from each individual were fixed in 10% buffered formalin, routinely processed and embedded in paraffin wax. Paraffin sections (5 µm) were cut on glass slides and stained with haematoxylin and eosin. The slides were examined under a light microscope and the magnified images of the tissues structure were captured for further study [43].

3.4.3. Blood Biomarker Assay

After 14 days of treatment with C. fistula seeds extract the mice blood were further evaluate for biochemical analysis. In the present study, the liver function was evaluated with serum levels of TBIL, ALP, ALT and AST.

3.4.4. Statistical analysis

Statistical analysis involved use of the Statistical Package for Social Sciences (SPSS). Data are given as the Mean ± SD; statistics were performed using t-tests and p values less than 5% were considered statistically significant (p < 0.05).

4. Conclusions

The present results show that methanol seed extract of C. fistula does not cause any apparent in vivo toxicity in an animal model. No death or signs of toxicity were observed in mice treated with extract at dose 5000 mg/kg thus establishing its safety in use. The histology examination revealed no changes in the architecture of the internal organs mice in both control and treated groups. Hence, C. fistula can be used as a medicinal agent in known dosages, especially in rural communities where conventional drugs are unaffordable because of their high cost. A detailed experimental analysis of its chronic toxicity is essential for further support of this drug.


S. Jo Thy Lachumy was supported by Universiti Sains Malaysia fellowship from Institute for Postgraduate Studies, Universiti Sins Malaysia.


  1. Humber, J.M. The role of complementary and alternative medicine: Accomodating pluralism. J. Am. Med. Assoc. 2002, 288, 1655–1656. [Google Scholar] [CrossRef]
  2. Newman, D.J.; Cragg, G.M.; Snader, K.M. Natural Products as Sources of New Drugs. J. Nat. Prod. 2003, 66, 1022–1103. [Google Scholar] [CrossRef]
  3. Prashanth Kumar, V.; Chauhan, N.S.; Padh, H.; Rajani, M. Search for antibacterial antifungal agents from selected Indian medicinal plants. J. Ethnopharmacol. 2006, 107, 182–188. [Google Scholar] [CrossRef]
  4. Perry, L.M. Medicinal Plants of East and South East Asia; MIT Press: Cambridge, UK, 1980. [Google Scholar]
  5. Alam, M.M.; Siddiqui, M.B.; Hussian, W. Treatment of diabetes through herbal drugs in rural India. Fitoterpia 1990, 61, 240–242. [Google Scholar]
  6. Asolkar, L.V.; Kakkar, K.K.; Chakre, O.J. Second Supplement to Glossary of Indian Medicinal Plant with Active Principles; Publication and Information Directorate: New Delhi, India, 1992; Volume I, p. 177. [Google Scholar]
  7. Satyavati, G.V.; Sharma, M. Medicinal Plant in India; ICMR: New Delhi, India, 1989. [Google Scholar]
  8. Biswas, K.; Ghosh, A.B. In Bharatia Banawassadhi, Calcutta University, Advancement of Learning; Calcutta University: Calcutta, India, 1973; Volume 2, p. 336. [Google Scholar]
  9. Kirtikar, K.R.; Basu, B.D. Indian Medicinal Plants; International Book Distributors: Dehradun, India, 1975; Volume 2, p. 858. [Google Scholar]
  10. Patel, D.; Karbhari, D.; Gulati, D.; Gokhale, D. Antipyretic and analgesic activities of Aconatum spicatum and Cassia fistula. Pharm. Biol. 1965, 157, 22–27. [Google Scholar]
  11. Markouk, M.; Bekkouche, K.; Larhsini, M.; Bousaid, M.; Lazrek, H.B.; Jana, M. Evaluation of some Moroccan medicinal plant extracts for larvicidal activity. J. Ethanopharmacol. 2000, 73, 293–297. [Google Scholar] [CrossRef]
  12. Bellini, M.F.; Cabrioti, L.N.; Terezan, A.P.; Jordao, B.Q.; Ribeiro, L.R.; Mantovani, M.S. Cytotoxicity and genotoxicity of Agaricus blazei methanolic extract fractions assessed using gene and chromosomal mutation assays. Genet. Mol. Biol. 2008, 31, 122–127. [Google Scholar] [CrossRef]
  13. Asante-Duah, K. Public Health Risk Assessment for Human Exposure to Chemicals (illustrateded.); Kluwer Academic Publishers: Dordrecht, The Netherlands, 2002; Volume 6. [Google Scholar]
  14. Joshi, C.S.; Priya, E.S.; Venkataraman, S. Acute and subacute toxicity studies on the polyherbal antidiabetic formulation diakyur in experimental animal models. J. Health Sci. 2007, 53, 245–249. [Google Scholar] [CrossRef]
  15. OECD, OECD Guidelines for Acute Toxicity of Chemicals; Organisation for Economic Co-operation and Development: Paris, France, 2001; No. 420.
  16. Vaghasiya, Y.K.; Shukla, V.J.; Chanda, S.V. Acute oral toxicity study of Pluchea arguta boiss extract in mice. J. Pharmacol. Toxicol. 2011, 6, 113–123. [Google Scholar] [CrossRef]
  17. Rang, H.P.; Dale, M.; Ritter, J. Pharmacology, 4th ed; Churchill Livingstone: New York, NY, USA, 2001; Volume 13. [Google Scholar]
  18. Sasidharan, S.; Darah, I.; Jain, K. In vivo and in vitro toxicity study of Gracilaria changii. Pharm. Biol. 2008, 46, 413–417. [Google Scholar] [CrossRef]
  19. Moshi, M.J. Brine shrimp toxicity evaluation of some Tanzanian plants used traditionally for the treatment of fungal infections. Afr. J. Tradit. Complement. Altern. Med. 2007, 4, 219–225. [Google Scholar]
  20. Syahmi, A.R.M.; Vijayarathna, S.; Sasidharan, S.; Yoga Latha, L.; Kwan, Y.P.; Lau, Y.L.; Shin, L.N.; Chen, Y. Acute oral toxicity and brine shrimp lethality of Elaeis guineensis Jacq., (Oil Palm leaf) methanol extract. Molecules 2010, 15, 8111–8121. [Google Scholar] [CrossRef]
  21. Lachumy, S.J.T.; Zuraini, Z.; Sasidharan, S. Antimicrobial activity and toxicity of methanol extract of Cassia fistula seeds. Res. J. Pharm. Biol. Chem. Sci. 2010, 1, 391–398. [Google Scholar]
  22. Walum, E.; Nilsson, M.; Clemedson, C.; Ekwall, B. The MEIC program and its implications for the prediction of acute human systemic toxicity. In Alternative Methods in Toxicology and theLife Sciences; Goldberg, A.M., van Zutphen, L.F.M., Eds.; Mary Ann Liebert: New York, NY, USA, 1995; Volume 11, pp. 275–282. [Google Scholar]
  23. Eaton, D.L.; Klaassen, C.D. Principles of toxicology. In Casarett and Doull’s Toxicology: The Basic Science of Poisons, 5th; Klaassen, C.D., Ed.; McGraw-Hill: New York, NY, USA, 1996; p. 13. [Google Scholar]
  24. Steven, K.R.; Mylecrdfaine, L. Issues in Chronic Toxicology. In Principles and Methods of Toxicology; Hayes, A.W., Ed.; Ravan Press: New York, NY, USA, 1994; p. 673. [Google Scholar]
  25. Iversen, P.O.; Nicolaysen, G. Water for life. J. Norw. Med. Assoc. 2003, 123, 3402–3405. [Google Scholar]
  26. Klaassen, C.D. Principles of Toxicology. In Casarett and Doull’s Toxicology: The Basic Science of Poisons, 5th ed; McGraw-Hill: New York, NY, USA, 2001; p. 13. [Google Scholar]
  27. Carol, S.A. Acute, Subchronic and Chronic Toxicology. In CRC Handbook of Toxicology; Michael, J.D., Mannfred, A.H., Eds.; CRC Press Inc.: Boca Raton, FL, USA, 1995; pp. 51–104. [Google Scholar]
  28. Raza, M.; Al-Shabanah, O.A.; El-Hadiyah, T.M.; Al-Majed, A.A. Effect of prolonged vigabatrin treatment on haematological and biochemical parameters in plasma, liver and kidney of Swiss albino mice. Sci. Pharm. 2002, 70, 135–145. [Google Scholar]
  29. Teo, S.D.; Stirling, S.; Thomas, A.; Kiorpes, A.; Vikram, K. A 90-day oral gavage toxicity study of D-methylphenidate and D, L methylphenidate in Sprague-dawley rats. Toxicology 2002, 179, 183–196. [Google Scholar] [CrossRef]
  30. Dybing, E.; Doe, J.; Groten, J.; Kleiner, J.; O’Brien, J. Hazard characterization of chemicals in food and diet: dose response, mechanism and extrapolation issues. Food Chem. Toxicol. 2002, 42, 237–282. [Google Scholar]
  31. Roopashree, T.S.; Raman, D.; Rani, R.H.S.; Narendra, C. Acute oral toxicity studies of antipsoriatic herbal mixture comprising of aqueous extracts of Calendula officinalis, Momordica charantia, Cassia tora and Azadirachta indica seed oil. Thai J. Pharm. Sci. 2009, 33, 74–83. [Google Scholar]
  32. Kennedy, G.L.; Ferenz, R.L.J.; Burgess, B.A. Estimation of acute toxicity in rats by determination of the appromate lethal dose rather than LD50. J. Appl. Toxicol. 1986, 6, 145–148. [Google Scholar]
  33. Ilavarasan, R.; Mallika, M.; Venkataraman, S. Anti-inflammatory and antioxidant activities of Cassia fistula Linn bark extracts. Afr. J. Tradit. 2005, 2, 70–85. [Google Scholar]
  34. Sangetha, S.; Zuraini, Z.; Sasidharan, S.; Suryani, S. Fungicidal effect and oral acute toxicity of Cassia spectabilis leaf extract. Jpn. J. Med. Mycol. 2008, 49, 299–304. [Google Scholar] [CrossRef]
  35. OECD, OECD Guideline for Testing of Chemicals. Repeated Dose 28-Day Oral Toxicity Study in Rodents; Organisation for Economic Co-operation and Development: Paris, France, 1995.
  36. Rhiouania, H.; El-Hilalya, J.; Israili, Z.H.; Lyoussia, B. Acute and subchronic toxicity of an aqueous extract of the leaves of Herniaria glabra in rodents. J. Ethnopharmacol. 2008, 118, 378–386. [Google Scholar] [CrossRef]
  37. Harizal, S.N.; Mansor, S.M.; Hasnan, J.; Tharakan, J.K.J.; Abdullah, J. Acute toxicity study of the standardized methanolic extract of Mitragyna speciosa Korth in Rodent. J. Ethnopharmacol. 2010, 131, 404–409. [Google Scholar] [CrossRef]
  38. Salawu, O.A.; Chindo, B.A.; Tijani, A.Y.; Obidike, I.C.; Salawu, T.A.; James Akingbasote, A. Acute and sub-acute toxicological evaluation of the methanolic stem bark extract of Crossopteryx febrifuga in rats. Afr. J. Pharm. Pharmacol. 2009, 3, 621–626. [Google Scholar]
  39. Akanmu, M.A.; Iwalewa, E.O.; Elujoba, A.A.; Adelusola, K.A. Toxicity potentials of Cassia fistula fruits as laxative with reference to senna. Afr. J. Biomed. Res. 2004, 7, 23–26. [Google Scholar]
  40. Alade, G.O.; Akanmu, M.A.; Obuotor, E.M.; Osasan, S.A.; Omobuwajo, O.R. Acute and oral subacute toxicity of methanolic extract of Bauhinia monandra leaf in rats. Afr. J. Pharm. Pharmacol. 2009, 3, 354–358. [Google Scholar]
  41. Adeneye, A.A.; Ajagbonna, O.P.; Adeleke, T.I.; Bello, S.O. Preliminary toxicity and phytochemical studies of the stem bark aqueous extract of Musanga cecropioides in rats. J. Ethnopharmacol. 2006, 105, 374–379. [Google Scholar] [CrossRef]
  42. Ajagbonna, O.P.; Onifade, K.I.; Suleiman, U. Haematological and biochemical changes in rats given extract of C. pocera. Sokoto J. Vet. Sci. 1999, 1, 3–12. [Google Scholar]
  43. Mcmanus, J.G.A.; Mowry, R.W. Staining Methods: Histological and Histochemical; Harper and Row: New York, NY, USA, 1984. [Google Scholar]
  • Sample Availability: Samples of the compounds are available from the authors.

Share and Cite

MDPI and ACS Style

Jothy, S.L.; Zakaria, Z.; Chen, Y.; Lau, Y.L.; Latha, L.Y.; Sasidharan, S. Acute Oral Toxicity of Methanolic Seed Extract of Cassia fistula in Mice. Molecules 2011, 16, 5268-5282.

AMA Style

Jothy SL, Zakaria Z, Chen Y, Lau YL, Latha LY, Sasidharan S. Acute Oral Toxicity of Methanolic Seed Extract of Cassia fistula in Mice. Molecules. 2011; 16(6):5268-5282.

Chicago/Turabian Style

Jothy, Subramanion L., Zuraini Zakaria, Yeng Chen, Yee Ling Lau, Lachimanan Yoga Latha, and Sreenivasan Sasidharan. 2011. "Acute Oral Toxicity of Methanolic Seed Extract of Cassia fistula in Mice" Molecules 16, no. 6: 5268-5282.

Article Metrics

Back to TopTop